Precigen stock hits 52-week high at 7.33 USD — See source for full details.
$PGEN
Price history, market instrument context, member research, and related headlines in one place.
PGEN key statistics
NasdaqGSUSD
52-week range
$3.0473%$8.98
Latest session $7.33–$7.70Precigen, Inc. (PGEN) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $7.36, down $0.13 (1.67%) from the previous close of $7.48. It has traded between $7.33 and $7.70 in the latest session. Over the past year it has ranged from $3.04 to $8.98, leaving it in the upper half of its 52-week range (73%). Reported volume for the session was 4.2M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Precigen GAAP EPS of $0.05 beats by $0.06, revenue of $54.98M beats by $27.15M — See source for full details.
Precigen earnings set to test gene therapy growth trajectory — See source for full details.
Form 4 Precigen Inc For: 4 August — See source for full details.
Precigen COO Rutul Shah sells $219,518 in company stock — See source for full details.
Form 144 PRECIGEN For: 3 August — See source for full details.
Loading $PGEN research…